Healthcare Services

Onychomycosis Treatment Market Developments and Growth Opportunities Across 2026–2030

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Onychomycosis Treatment Market By 2030 Starting From Its 2026 Size?

The onychomycosis treatment market has experienced robust expansion in recent times. This market is projected to expand from $3.91 billion in 2025 to reach $4.16 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 6.5%. Historically, this expansion has been driven by factors such as the widespread occurrence of onychomycosis, the constrained access to cutting-edge antifungal medications, heightened understanding of nail hygiene, a surge in the need for topical antifungal therapies, and an uptick in fungal infections among older demographics.

The onychomycosis treatment market is projected to experience robust expansion in the coming years, set to reach $5.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. The anticipated growth during this period can be attributed to several factors, including advancements in laser and photodynamic therapy technologies, a greater uptake of combination treatment strategies, an increase in telemedicine consultations specifically for dermatology, the widening distribution networks of hospital and retail pharmacies, and intensified research and development efforts targeting drug-resistant fungal strains. Key trends anticipated for the forecast period encompass a growing preference for combination drug and laser therapies, an increased application of photodynamic therapy for infections that are difficult to treat, heightened awareness concerning preventive nail care practices, the expanded deployment of AI-based diagnostic tools for fungal infections, and the broader adoption of telemedicine for managing onychomycosis.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12941&type=smp

Which Market Drivers Are Supporting The Expansion Of The Onychomycosis Treatment Market?

The onychomycosis treatment market is anticipated to experience growth driven by the escalating number of fungal infections. Fungal infections are microbial ailments stemming from various fungi, which can affect different parts of the body or manifest as specific conditions. Onychomycosis, a fungal nail infection, is frequently addressed with oral or topical antifungal remedies designed to eliminate fungal growth and support the regeneration of healthy nails. As an illustration, in May 2025, the UK Health Security Agency, a UK-based government agency, reported that in 2024, the rate of bloodstream infections caused by yeasts across England had climbed by 31% since 2015 and by 4% from 2023. Furthermore, the period between 2023 and 2024 observed a 4% rise in laboratory reports of fungemia due to yeasts in England, increasing from 2,170 to 2,247 reports. Thus, the increasing occurrence of fungal infections is stimulating the expansion of the onychomycosis treatment market.

Which Segment Categories Define The Onychomycosis Treatment Market?

The onychomycosis treatment market covered in this report is segmented –

1) By Type: Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis, Candida Onychomycosis, Other Types

2) By Treatment Type: Drugs, Laser Therapy, Photodynamic Therapy

3) By Age Group: 0 To 18 Years, 18 To 39 Years, 40 To 64 Years, 65 Years And Above

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

What Key Trends Are Influencing The Development Of The Onychomycosis Treatment Market?

Major companies operating in the onychomycosis treatment market are focused on developing new products, such as MOB-015, and obtaining their approval from federal agencies to gain a competitive edge in the market. For instance, in June 2023, Moberg Pharma AB, a Sweden-based pharmaceutical company, received approval for MOB-015 in the European Union for the treatment of mild to moderate fungal infections of the nails in adults. This European Union’s approval represents the first global marketing authorization for this innovative onychomycosis medication. Two Phase 3 trials supporting MOB-015’s approval demonstrated an improved mycological cure (76% vs. up to 42% for comparators) and a significantly greater total cure rate than the vehicle, without any serious adverse effects. The topical terbinafine formulation MOB-015 allows effective terbinafine concentrations to reach the nail and nail bed, bypassing the risk of systemic exposure associated with oral terbinafine treatment.

Who Are The Top Companies Competing In The Onychomycosis Treatment Market?

Major companies operating in the onychomycosis treatment market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Drugs Ltd., Sun Pharmaceutical Industries Limited, Cadila Pharmaceuticals Ltd., Dr. Reddys Laboratories Ltd., Intas Pharmaceuticals Limited, Cipla Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Aurobindo Pharma Limited, Alkem Laboratories Limited, Jubilant Life Sciences Ltd., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Biocon Limited, Emcure Pharmaceuticals Limited, Alembic Pharmaceuticals Ltd., Laurus Labs Limited, Strides Pharma Science Limited, Aarti Drugs Ltd., NATCO Pharma Ltd., Unichem Laboratories Ltd., Indoco Remedies Ltd., Apex Laboratories Pvt. Ltd., Wockhardt Ltd.

Read the full onychomycosis treatment market report here:

https://www.thebusinessresearchcompany.com/report/onychomycosis-treatment-global-market-report

How Is The Onychomycosis Treatment Market Distributed Across Key Geographic Regions?

North America was the largest region in the onychomycosis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onychomycosis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Onychomycosis Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12941&type=smp

Browse Through More Reports Similar to the Global Onychomycosis Treatment Market 2026, By The Business Research Company

Onychomycosis Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/onychomycosis-treatment-global-market-report

Systemic Aspergillosis And Systemic Candidiasis Global Market Report

https://www.thebusinessresearchcompany.com/report/systemic-aspergillosis-and-systemic-candidiasis-global-market-report

Invasive Fungal Infections Global Market Report

https://www.thebusinessresearchcompany.com/report/invasive-fungal-infections-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795